2B53.0

ICD-11 MMS 2026-01

Myxofibrosarcoma, primary site

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Myxofibrosarcoma, primary site
  • fibromyxosarcoma of unspecified site

Exclusions from above levels

  • 2A01.1 – Mesenchymal tumour of meninges
  • 2A02.1 – Tumours of cranial or paraspinal nerves
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
Show allHide
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2B53.1 – Fibroblastic or myofibroblastic tumour of skin
  • 2B53.Y – Other specified fibroblastic or myofibroblastic tumour, primary site
  • 2B53.Z – Fibroblastic or myofibroblastic tumour, primary site, unspecified

Foundation entity

Myxofibrosarcoma, primary site – http://id.who.int/icd/entity/405689402

Allowed postcoordination axes

Part of: 2B53: Fibroblastic or myofibroblastic tumour, primary site › 02: Neoplasms